Nano biotechnology combines nano technology and biotechnology including special physicochemical and biological properties of nanostructures and their applications in numerous fieldslike medicine and agriculture. Nanobiotechnology is one of the most promising technologies in the 21st century. It plays a major role in developing and implementing many useful tools in the study of life. Its application in medicine involves disease diagnosis, target-specific drug delivery and molecular imaging. It also has application in agriculture and food. The factors such as increasing demand for the innovative drug in the pharmaceutical industry, rise in the application of nano biotechnology electronics, energy production and biomaterials and increased research & development investment are the key drivers of the global nano biotechnology market.
This report aims to provide a comprehensive presentation of the global market for NanoBioTechnology (NBT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NanoBioTechnology (NBT). This report contains market size and forecasts of NanoBioTechnology (NBT) in global, including the following market information:
Global NanoBioTechnology (NBT) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global NanoBioTechnology (NBT) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
0-10 nm Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NanoBioTechnology (NBT) include Ablynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTecbioanalytics GmbH (Germany) and Nanobiotix(France), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NanoBioTechnology (NBT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NanoBioTechnology (NBT) Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, by Type, 2022 (%)
0-10 nm
10-100 nm
Global NanoBioTechnology (NBT) Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, by Application, 2022 (%)
Pharmaceuticals
Medical Research
Food and Agriculture
Others
Global NanoBioTechnology (NBT) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global NanoBioTechnology (NBT) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NanoBioTechnology (NBT) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NanoBioTechnology (NBT) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ablynx (Belgium)
Nami Therapeutics (US)
Celgene Corporation (US)
Nanophase Technologies Corporation (US)
Sigma-Aldrich (US)
SkyePharma Pharmaceuticals (France)
Nano Bridging Molecules SA (Switzerland)
XanTecbioanalytics GmbH (Germany)
Nanobiotix(France)
Dabur Pharma (India)
Outline of Major Chapters:
Chapter 1: Introduces the definition of NanoBioTechnology (NBT), market overview.
Chapter 2: Global NanoBioTechnology (NBT) market size in revenue.
Chapter 3: Detailed analysis of NanoBioTechnology (NBT) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NanoBioTechnology (NBT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NanoBioTechnology (NBT) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NanoBioTechnology (NBT) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NanoBioTechnology (NBT) Overall Market Size
2.1 Global NanoBioTechnology (NBT) Market Size: 2022 VS 2032
2.2 Global NanoBioTechnology (NBT) Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NanoBioTechnology (NBT) Players in Global Market
3.2 Top Global NanoBioTechnology (NBT) Companies Ranked by Revenue
3.3 Global NanoBioTechnology (NBT) Revenue by Companies
3.4 Top 3 and Top 5 NanoBioTechnology (NBT) Companies in Global Market, by Revenue in 2022
3.5 Global Companies NanoBioTechnology (NBT) Product Type
3.6 Tier 1, Tier 2 and Tier 3 NanoBioTechnology (NBT) Players in Global Market
3.6.1 List of Global Tier 1 NanoBioTechnology (NBT) Companies
3.6.2 List of Global Tier 2 and Tier 3 NanoBioTechnology (NBT) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NanoBioTechnology (NBT) Market Size Markets, 2022 & 2032
4.1.2 0-10 nm
4.1.3 10-100 nm
4.2 By Type - Global NanoBioTechnology (NBT) Revenue & Forecasts
4.2.1 By Type - Global NanoBioTechnology (NBT) Revenue, 2018-2023
4.2.2 By Type - Global NanoBioTechnology (NBT) Revenue, 2024-2032
4.2.3 By Type - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NanoBioTechnology (NBT) Market Size, 2022 & 2032
5.1.2 Pharmaceuticals
5.1.3 Medical Research
5.1.4 Food and Agriculture
5.1.5 Others
5.2 By Application - Global NanoBioTechnology (NBT) Revenue & Forecasts
5.2.1 By Application - Global NanoBioTechnology (NBT) Revenue, 2018-2023
5.2.2 By Application - Global NanoBioTechnology (NBT) Revenue, 2024-2032
5.2.3 By Application - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global NanoBioTechnology (NBT) Market Size, 2022 & 2032
6.2 By Region - Global NanoBioTechnology (NBT) Revenue & Forecasts
6.2.1 By Region - Global NanoBioTechnology (NBT) Revenue, 2018-2023
6.2.2 By Region - Global NanoBioTechnology (NBT) Revenue, 2024-2032
6.2.3 By Region - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America NanoBioTechnology (NBT) Revenue, 2018-2032
6.3.2 US NanoBioTechnology (NBT) Market Size, 2018-2032
6.3.3 Canada NanoBioTechnology (NBT) Market Size, 2018-2032
6.3.4 Mexico NanoBioTechnology (NBT) Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe NanoBioTechnology (NBT) Revenue, 2018-2032
6.4.2 Germany NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.3 France NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.4 U.K. NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.5 Italy NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.6 Russia NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.7 Nordic Countries NanoBioTechnology (NBT) Market Size, 2018-2032
6.4.8 Benelux NanoBioTechnology (NBT) Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia NanoBioTechnology (NBT) Revenue, 2018-2032
6.5.2 China NanoBioTechnology (NBT) Market Size, 2018-2032
6.5.3 Japan NanoBioTechnology (NBT) Market Size, 2018-2032
6.5.4 South Korea NanoBioTechnology (NBT) Market Size, 2018-2032
6.5.5 Southeast Asia NanoBioTechnology (NBT) Market Size, 2018-2032
6.5.6 India NanoBioTechnology (NBT) Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America NanoBioTechnology (NBT) Revenue, 2018-2032
6.6.2 Brazil NanoBioTechnology (NBT) Market Size, 2018-2032
6.6.3 Argentina NanoBioTechnology (NBT) Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NanoBioTechnology (NBT) Revenue, 2018-2032
6.7.2 Turkey NanoBioTechnology (NBT) Market Size, 2018-2032
6.7.3 Israel NanoBioTechnology (NBT) Market Size, 2018-2032
6.7.4 Saudi Arabia NanoBioTechnology (NBT) Market Size, 2018-2032
6.7.5 UAE NanoBioTechnology (NBT) Market Size, 2018-2032
7 NanoBioTechnology (NBT) Companies Profiles
7.1 Ablynx (Belgium)
7.1.1 Ablynx (Belgium) Company Summary
7.1.2 Ablynx (Belgium) Business Overview
7.1.3 Ablynx (Belgium) NanoBioTechnology (NBT) Major Product Offerings
7.1.4 Ablynx (Belgium) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.1.5 Ablynx (Belgium) Key News & Latest Developments
7.2 Nami Therapeutics (US)
7.2.1 Nami Therapeutics (US) Company Summary
7.2.2 Nami Therapeutics (US) Business Overview
7.2.3 Nami Therapeutics (US) NanoBioTechnology (NBT) Major Product Offerings
7.2.4 Nami Therapeutics (US) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.2.5 Nami Therapeutics (US) Key News & Latest Developments
7.3 Celgene Corporation (US)
7.3.1 Celgene Corporation (US) Company Summary
7.3.2 Celgene Corporation (US) Business Overview
7.3.3 Celgene Corporation (US) NanoBioTechnology (NBT) Major Product Offerings
7.3.4 Celgene Corporation (US) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.3.5 Celgene Corporation (US) Key News & Latest Developments
7.4 Nanophase Technologies Corporation (US)
7.4.1 Nanophase Technologies Corporation (US) Company Summary
7.4.2 Nanophase Technologies Corporation (US) Business Overview
7.4.3 Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Major Product Offerings
7.4.4 Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.4.5 Nanophase Technologies Corporation (US) Key News & Latest Developments
7.5 Sigma-Aldrich (US)
7.5.1 Sigma-Aldrich (US) Company Summary
7.5.2 Sigma-Aldrich (US) Business Overview
7.5.3 Sigma-Aldrich (US) NanoBioTechnology (NBT) Major Product Offerings
7.5.4 Sigma-Aldrich (US) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.5.5 Sigma-Aldrich (US) Key News & Latest Developments
7.6 SkyePharma Pharmaceuticals (France)
7.6.1 SkyePharma Pharmaceuticals (France) Company Summary
7.6.2 SkyePharma Pharmaceuticals (France) Business Overview
7.6.3 SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Major Product Offerings
7.6.4 SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.6.5 SkyePharma Pharmaceuticals (France) Key News & Latest Developments
7.7 Nano Bridging Molecules SA (Switzerland)
7.7.1 Nano Bridging Molecules SA (Switzerland) Company Summary
7.7.2 Nano Bridging Molecules SA (Switzerland) Business Overview
7.7.3 Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Major Product Offerings
7.7.4 Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.7.5 Nano Bridging Molecules SA (Switzerland) Key News & Latest Developments
7.8 XanTecbioanalytics GmbH (Germany)
7.8.1 XanTecbioanalytics GmbH (Germany) Company Summary
7.8.2 XanTecbioanalytics GmbH (Germany) Business Overview
7.8.3 XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Major Product Offerings
7.8.4 XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.8.5 XanTecbioanalytics GmbH (Germany) Key News & Latest Developments
7.9 Nanobiotix(France)
7.9.1 Nanobiotix(France) Company Summary
7.9.2 Nanobiotix(France) Business Overview
7.9.3 Nanobiotix(France) NanoBioTechnology (NBT) Major Product Offerings
7.9.4 Nanobiotix(France) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.9.5 Nanobiotix(France) Key News & Latest Developments
7.10 Dabur Pharma (India)
7.10.1 Dabur Pharma (India) Company Summary
7.10.2 Dabur Pharma (India) Business Overview
7.10.3 Dabur Pharma (India) NanoBioTechnology (NBT) Major Product Offerings
7.10.4 Dabur Pharma (India) NanoBioTechnology (NBT) Revenue in Global Market (2018-2023)
7.10.5 Dabur Pharma (India) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. NanoBioTechnology (NBT) Market Opportunities & Trends in Global Market
Table 2. NanoBioTechnology (NBT) Market Drivers in Global Market
Table 3. NanoBioTechnology (NBT) Market Restraints in Global Market
Table 4. Key Players of NanoBioTechnology (NBT) in Global Market
Table 5. Top NanoBioTechnology (NBT) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global NanoBioTechnology (NBT) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global NanoBioTechnology (NBT) Revenue Share by Companies, 2018-2023
Table 8. Global Companies NanoBioTechnology (NBT) Product Type
Table 9. List of Global Tier 1 NanoBioTechnology (NBT) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NanoBioTechnology (NBT) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NanoBioTechnology (NBT) Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - NanoBioTechnology (NBT) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - NanoBioTechnology (NBT) Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global NanoBioTechnology (NBT) Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - NanoBioTechnology (NBT) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - NanoBioTechnology (NBT) Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global NanoBioTechnology (NBT) Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global NanoBioTechnology (NBT) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global NanoBioTechnology (NBT) Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America NanoBioTechnology (NBT) Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe NanoBioTechnology (NBT) Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia NanoBioTechnology (NBT) Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America NanoBioTechnology (NBT) Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa NanoBioTechnology (NBT) Revenue, (US$, Mn), 2024-2032
Table 30. Ablynx (Belgium) Company Summary
Table 31. Ablynx (Belgium) NanoBioTechnology (NBT) Product Offerings
Table 32. Ablynx (Belgium) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 33. Ablynx (Belgium) Key News & Latest Developments
Table 34. Nami Therapeutics (US) Company Summary
Table 35. Nami Therapeutics (US) NanoBioTechnology (NBT) Product Offerings
Table 36. Nami Therapeutics (US) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 37. Nami Therapeutics (US) Key News & Latest Developments
Table 38. Celgene Corporation (US) Company Summary
Table 39. Celgene Corporation (US) NanoBioTechnology (NBT) Product Offerings
Table 40. Celgene Corporation (US) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Corporation (US) Key News & Latest Developments
Table 42. Nanophase Technologies Corporation (US) Company Summary
Table 43. Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Product Offerings
Table 44. Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 45. Nanophase Technologies Corporation (US) Key News & Latest Developments
Table 46. Sigma-Aldrich (US) Company Summary
Table 47. Sigma-Aldrich (US) NanoBioTechnology (NBT) Product Offerings
Table 48. Sigma-Aldrich (US) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 49. Sigma-Aldrich (US) Key News & Latest Developments
Table 50. SkyePharma Pharmaceuticals (France) Company Summary
Table 51. SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Product Offerings
Table 52. SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 53. SkyePharma Pharmaceuticals (France) Key News & Latest Developments
Table 54. Nano Bridging Molecules SA (Switzerland) Company Summary
Table 55. Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Product Offerings
Table 56. Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 57. Nano Bridging Molecules SA (Switzerland) Key News & Latest Developments
Table 58. XanTecbioanalytics GmbH (Germany) Company Summary
Table 59. XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Product Offerings
Table 60. XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 61. XanTecbioanalytics GmbH (Germany) Key News & Latest Developments
Table 62. Nanobiotix(France) Company Summary
Table 63. Nanobiotix(France) NanoBioTechnology (NBT) Product Offerings
Table 64. Nanobiotix(France) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 65. Nanobiotix(France) Key News & Latest Developments
Table 66. Dabur Pharma (India) Company Summary
Table 67. Dabur Pharma (India) NanoBioTechnology (NBT) Product Offerings
Table 68. Dabur Pharma (India) NanoBioTechnology (NBT) Revenue (US$, Mn) & (2018-2023)
Table 69. Dabur Pharma (India) Key News & Latest Developments
List of Figures
Figure 1. NanoBioTechnology (NBT) Segment by Type in 2022
Figure 2. NanoBioTechnology (NBT) Segment by Application in 2022
Figure 3. Global NanoBioTechnology (NBT) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NanoBioTechnology (NBT) Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global NanoBioTechnology (NBT) Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NanoBioTechnology (NBT) Revenue in 2022
Figure 8. By Type - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 9. By Application - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 10. By Type - Global NanoBioTechnology (NBT) Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 12. By Application - Global NanoBioTechnology (NBT) Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 14. By Region - Global NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 15. By Country - North America NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 16. US NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 17. Canada NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 20. Germany NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 21. France NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 23. Italy NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 24. Russia NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 28. China NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 29. Japan NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 32. India NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 34. Brazil NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa NanoBioTechnology (NBT) Revenue Market Share, 2018-2032
Figure 37. Turkey NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 38. Israel NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 40. UAE NanoBioTechnology (NBT) Revenue, (US$, Mn), 2018-2032
Figure 41. Ablynx (Belgium) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Nami Therapeutics (US) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Corporation (US) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sigma-Aldrich (US) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nanobiotix(France) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dabur Pharma (India) NanoBioTechnology (NBT) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
